Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 2, 2007, Pages 113-116

  Boulanger, Denis ^a   Dieng, Yemou ^b   Cisse, Badara ^a,b,c   Remoue, Franck ^a   Capuano, Frederic ^a   Dieme, Jean Louis ^a   Ndiaye, Tofene ^a   Sokhna, Cheikh ^a   Trape, Jean François ^a   Greenwood, Brian ^c   Simondon, Francois ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Artemisinin based combination therapy; Artesunate; Malaria; Plasmodium falciparum; Schistosoma haematobium; Senegal

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ANTISCHISTOSOMAL AGENT; ARTESUNATE; FANSIDAR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; MALARIA; MALARIA CONTROL; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SENEGAL; SINGLE DRUG DOSE; URINE LEVEL;

AMODIAQUINE; ANIMALS; ANTHELMINTICS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA; PILOT PROJECTS; PYRIMETHAMINE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SESQUITERPENES; SULFADOXINE; TREATMENT OUTCOME;

ARTESUNATE; PLASMODIUM FALCIPARUM; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM;

EID: 33845196585     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.03.003     Document Type: Article

References (14)

1. Borrmann S., Szlezak N., Faucher J.F., Matsiegui P.B., Neubauer R., Binder R.K., Lell B., and Kremsner P.G. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J. Infect. Dis. 184 (2001) 1363-1366
2. Briand V., Watier L., Le Hesran J.Y., Garcia A., and Cot M. Coinfection with Plasmodium falciparum and Schistosoma haematobium: protective effect of schistosomiasis on malaria in Senegalese children?. Am. J. Trop. Med. Hyg. 72 (2005) 702-707
3. Cisse B., Sokhna C., Boulanger D., Milet J., Ba E., Richardson K., Hallett R., Sutherland C., Simondon K., Simondon F., Alexander N., Gaye O., Targett G., Lines J., Greenwood B., and Trape J.-F. Seasonal intermittent treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367 (2006) 659-667
4. De Clercq D., Vercruysse J., Kongs A., Verle P., Dompnier J.P., and Faye P.C. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop. 82 (2002) 61-66
5. Delaunay V., Etard J.F., Preziosi M.P., Marra A., and Simondon F. Decline of infant and child mortality rates in rural Senegal over a 37-year period (1963-1999). Int. J. Epidemiol. 30 (2001) 1286-1293
6. Inyang-Etoh P.C., Ejezie G.C., Useh M.F., and Inyang-Etoh E.C. Efficacy of artesunate in the treatment of urinary schistosomiasis, in an endemic community in Nigeria. Ann. Trop. Med. Parasitol. 98 (2004) 491-499
7. Majori G. [Combined antimalarial therapy using artemisinin]. Parassitologia 46 (2004) 85-87 [in Italian].
8. Menard D., Matsika-Claquin M.D., Djalle D., Yapou F., Manirakiza A., Dolmazon V., Sarda J., and Talarmin A. Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 73 (2005) 616-621
9. Olliaro P., Taylor W.R., and Rigal J. Controlling malaria: challenges and solutions. Trop. Med. Int. Health 6 (2001) 922-927
10. Trape J.F., Pison G., Preziosi M.P., Enel C., Desgrees du Lou A., Delaunay V., Samb B., Lagarde E., Molez J.F., and Simondon F. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. III 321 (1998) 689-697
11. Utzinger J., Xiao S., Keiser J., Chen M., Zheng J., and Tanner M. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr. Med. Chem. 8 (2001) 1841-1860
12. Utzinger J., Keiser J., Shuhua X., Tanner M., and Singer B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 47 (2003) 1487-1495
13. WHO, 2000. WHO Expert Committee on Malaria. World Health Organization, Geneva, Technical Report Series No. 892.
14. Xiao S.H. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop. 96 (2005) 153-167